Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

NCT07712172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2026-07-17

No results posted yet for this study

Summary

The goal of this observational study is to quantify activity and extent of disease in patients with GPA using 18F-FDG PET/CT. The main questions it aims to answer are:

Sensitivity of 18 F-FDG PET/CT in patients with GPA? Correlation of 18F-FDG PET/CT semi-quantitative parameters with BVAS v3?

Conditions

  • Granulomatosis With Polyangiitis (Wegener's)

Interventions

DRUG

18F-FDG

18 F-FDG PET/CT was done for patients with active GPA

DEVICE

18F-FDG PET/CT

Use of 18F-FDG PET/CT scan in patients with active GPA

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    lead OTHER

Principal Investigators

  • Dr Harmandeep Singh, MD · Postgraduate Institute of Medical Education and Research, Chandigarh, 160012

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-05-30
Completion
2026-05-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07712172 on ClinicalTrials.gov